International Biotechnology Trust PLC Enanta Pharmaceuticals Inc Transaction History

International Biotechnology Trust PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$60.19 - $97.37 $2.41 Million - $3.89 Million	-40,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$41.02 - $58.65 $244,192 - $349,143	5,953 Added 17.48%	40,000 $2.26 Million
Q2 2021 Aug 11, 2021	BUY	$43.76 - $53.11 $1.49 Million - $1.81 Million	34,047 New	34,047 $1.5 Million
Q3 2020 Dec 01, 2020	SELL	$43.36 - $53.53 $2.02 Million - $2.49 Million	-46,500 Closed	0 $0
Q1 2020 May 18, 2020	BUY	$40.22 - $62.0 $1.87 Million - $2.88 Million	46,500 New	46,500 $2.39 Million
Q2 2019 Aug 14, 2019	SELL	$81.3 - $97.35 $4.96 Million - $5.94 Million	-61,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$69.08 - $105.66 $1.24 Million - $1.9 Million	18,000 Added 41.86%	61,000 $5.83 Million
Q4 2018 Feb 14, 2019	BUY	$65.41 - $84.65 $2.81 Million - $3.64 Million	43,000 New	43,000 $2.39 Million

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.